Dr Matthew Thomas Hendricks, OD - Medicare Optometrist in Saint Paul, MN

Dr Matthew Thomas Hendricks, OD is a medicare enrolled "Optometrist" provider in Saint Paul, Minnesota. He went to Pacific University - College Of Optometry and graduated in 2018 and has 6 years of diverse experience with area of expertise as Optometry. He is a member of the group practice Healthpartners Medical Group and his current practice location is 401 Phalen Blvd, Saint Paul, Minnesota. You can reach out to his office (for appointments etc.) via phone at (651) 254-7500.

Dr Matthew Thomas Hendricks is licensed to practice in Minnesota (license number 3656) and he also participates in the medicare program. He may accept medicare assignments (which means he may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and his NPI Number is 1104391325.

Contact Information

Dr Matthew Thomas Hendricks, OD
401 Phalen Blvd,
Saint Paul, MN 55130-5302
(651) 254-7500
Not Available



Healthcare Provider's Profile

Full NameDr Matthew Thomas Hendricks
GenderMale
SpecialityOptometry
Experience6 Years
Location401 Phalen Blvd, Saint Paul, Minnesota
Accepts Medicare AssignmentsMay be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Matthew Thomas Hendricks attended and graduated from Pacific University - College Of Optometry in 2018
  NPI Data:
  • NPI Number: 1104391325
  • Provider Enumeration Date: 10/04/2018
  • Last Update Date: 01/10/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 2062757347
  • Enrollment ID: I20200106001662

Medical Identifiers

Medical identifiers for Dr Matthew Thomas Hendricks such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1104391325NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 3656 (Minnesota)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Healthpartners Medical Group17592939541430

News Archive

Study identifies potential pathway to improve rate at which the body burns calories

Researchers say they have identified a potential pathway in our muscle tissue to improve the rate at which our bodies burn calories.

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).

With health debate resolved, investors see continued health sector growth

After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Matthew Thomas Hendricks allows following entities to bill medicare on his behalf.
Provider NameGroup Health Plan Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1710924683
PECOS PAC ID: 1759293954
Enrollment ID: O20031105000417

News Archive

Study identifies potential pathway to improve rate at which the body burns calories

Researchers say they have identified a potential pathway in our muscle tissue to improve the rate at which our bodies burn calories.

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).

With health debate resolved, investors see continued health sector growth

After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."

Read more Medical News

› Verified 9 days ago

Provider NameBrokea Inc.
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1346453735
PECOS PAC ID: 9537328075
Enrollment ID: O20120405000013

News Archive

Study identifies potential pathway to improve rate at which the body burns calories

Researchers say they have identified a potential pathway in our muscle tissue to improve the rate at which our bodies burn calories.

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).

With health debate resolved, investors see continued health sector growth

After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Matthew Thomas Hendricks is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Matthew Thomas Hendricks, OD
8170 33rd Ave S # Ms 21110q,
Minneapolis, MN 55425-4516

Ph: () -
Dr Matthew Thomas Hendricks, OD
401 Phalen Blvd,
Saint Paul, MN 55130-5302

Ph: (651) 254-7500

News Archive

Study identifies potential pathway to improve rate at which the body burns calories

Researchers say they have identified a potential pathway in our muscle tissue to improve the rate at which our bodies burn calories.

Positive data from Tarsa's OSTORA Phase III trial on postmenopausal osteoporosis

Tarsa Therapeutics today presented positive safety and efficacy data from its Phase III ORACAL trial of OSTORA-, the company's oral recombinant salmon calcitonin tablet in development for the treatment of postmenopausal osteoporosis.

RXi receives SBIR grant to enable discovery and preclinical development of sd-rxRNAs

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that it was awarded a Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) of the National Institutes of Health (NIH).

With health debate resolved, investors see continued health sector growth

After months of uncertainty during the health-overhaul debate, financial analysts and mutual fund managers are feeling more stable and seeing upsides from the new law, The New York Times reports. "There does not seem to be any onerous cost control," one analyst said. Another added, "There is just an expansion of coverage [and] not a lot of surprises."

Read more News

› Verified 9 days ago


Optometrist in Saint Paul, MN

Kennedy Eye Associates
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1790 Lexington Ave N, Saint Paul, MN 55113
Phone: 651-488-6771    Fax: 651-488-5576
Maggie Scott, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1360 University Ave W Ste 106, Saint Paul, MN 55104
Phone: 651-251-0317    
Dr. Julie M Blenker, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 261 Ruth St N Ste E, Saint Paul, MN 55119
Phone: 651-739-5173    Fax: 651-739-8907
John Heyen, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1020 Bandana Blvd W, Saint Paul, MN 55108
Phone: 651-241-7000    
Broecker Eye & Optical
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2356 University Ave W, Suite 260, Saint Paul, MN 55114
Phone: 651-645-8124    Fax: 651-645-8125
Dr. David Andrew Spande, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1300 University Ave W, Optical Clinic, Saint Paul, MN 55104
Phone: 651-641-6181    Fax: 651-646-3292

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.